Literature DB >> 2047709

Differences in the sensitivity of Fischer and Sprague-Dawley rats to aminoglycoside nephrotoxicity.

M K Reinhard1, G H Hottendorf, E D Powell.   

Abstract

Because of the anecdotal but unconfirmed inferences of the greater sensitivity of Fischer rats to aminoglycoside nephrotoxicity, an intrastudy comparison of the sensitivity of Fischer and Sprague-Dawley rats to aminoglycoside nephrotoxicity was undertaken. Tobramycin was administered at 3 dose levels to each strain of rat for 10 days. Nephrotoxicity was evaluated utilizing a spectrum of both functional and morphologic assessments of renal proximal tubular integrity. The results confirm that the aged matched Fischer rat is more sensitive to the nephrotoxic effect of tobramycin than the Sprague-Dawley. These results also suggest an opportunity to study quantitative and perhaps qualitative differences in pathogenic mechanisms of aminoglycoside nephrotoxicity in a single laboratory animal species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047709     DOI: 10.1177/019262339101900108

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  7 in total

1.  Renal glomerular and tubular injury after gastric bypass in obese rats.

Authors:  Benjamin K Canales; Leticia Reyes; Mary K Reinhard; Saeed R Khan; Carolina G Goncalves; Michael M Meguid
Journal:  Nutrition       Date:  2011-07-01       Impact factor: 4.008

2.  Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model.

Authors:  Manjunath P Pai; Wen Zhen Chen; Adinoyi Garba; Huadong Cui; Barbara Zaffo; Hassan A N El-Fawal; Shaker A Mousa
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

3.  Effects of polyaspartic acid on pharmacokinetics of tobramycin in two strains of rat.

Authors:  M K Reinhard; I Bekersky; T W Sanders; B J Harris; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

4.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

5.  Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis.

Authors:  Kyoung Hee Han; Bora Kim; Sang Chun Ji; Hee Gyung Kang; Hae Il Cheong; Joo-Youn Cho; Il-Soo Ha
Journal:  Metabolites       Date:  2020-04-24

6.  Antiviral Activity Against Infectious Bronchitis Virus and Bioactive Components of Hypericum perforatum L.

Authors:  Huijie Chen; Ishfaq Muhammad; Yue Zhang; Yudong Ren; Ruili Zhang; Xiaodan Huang; Lei Diao; Haixin Liu; Xunliang Li; Xiaoqi Sun; Ghulam Abbas; Guangxing Li
Journal:  Front Pharmacol       Date:  2019-10-29       Impact factor: 5.810

7.  Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats.

Authors:  Robert W Regenhardt; Adam P Mecca; Fiona Desland; Phillip F Ritucci-Chinni; Jacob A Ludin; David Greenstein; Cristina Banuelos; Jennifer L Bizon; Mary K Reinhard; Colin Sumners
Journal:  Exp Physiol       Date:  2013-10-18       Impact factor: 2.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.